Biochemical Characterisation of the Short Isoform of Histone N-Terminal Acetyltransferase NAA40
N-alpha-acetyltransferase 40 (NAA40) is an evolutionarily conserved N-terminal acetyltransferase (NAT) linked to oncogenesis and chemoresistance. A recent study reported the generation of a second, shorter NAA40 isoform (NAA40<sup>S</sup>) through alternative translation, which we proceeded to further characterise. Notably, recombinant NAA40<sup>S</sup> had a greater in vitro enzymatic activity and affinity towards its histone H2A/H4 substrates compared to full-length NAA40 (NAA40<sup>L</sup>). Within cells, NAA40<sup>S</sup> was enzymatically active, based on its ability to suppress the H2A/H4S1Ph antagonistic mark in CRISPR-generated <i>NAA40</i> knockout cells. Finally, we show that in addition to alternative translation, the NAA40<sup>S</sup> isoform could be derived from a primate and testis-specific transcript, which may align with the "out-of-testis" origin of recently evolved genes and isoforms. To summarise, our data reveal an even greater functional divergence between the two NAA40 isoforms than had been previously recognised.
Authors
- Cem Özdemir
- Costas Koufaris (ORCID: https://orcid.org/0000-0002-1222-5130)
- Vicky Nicolaidou (ORCID: https://orcid.org/0000-0003-1017-2677)
- Ariel Klavaris
- Antonis Kirmizis (ORCID: https://orcid.org/0000-0002-3748-8711)
- Kyle M. Miller (ORCID: https://orcid.org/0000-0002-4544-0013)
- Maria Kouma
Institutions
- University of Nicosia (CY)
- University of Cyprus (CY)
- The University of Texas at Austin (US)
Publication Details
- Journal
- Biomolecules
- Published
- 2024-09-02
- DOI
- https://doi.org/10.3390/biom14091100
- Citations
- 4
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 1.13
Funders
- Cancer Research Institute
- Cancer Prevention and Research Institute of Texas
- University of Cyprus
- Research and Innovation Foundation
- European Regional Development Fund
- National Cancer Institute